0001161697-22-000547.txt : 20221115 0001161697-22-000547.hdr.sgml : 20221115 20221115170021 ACCESSION NUMBER: 0001161697-22-000547 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221111 FILED AS OF DATE: 20221115 DATE AS OF CHANGE: 20221115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Del Carmen Jeffrey CENTRAL INDEX KEY: 0001816477 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 221391908 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form_4.xml FORM 4 FOR 11-11-2022 X0306 4 2022-11-11 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001816477 Del Carmen Jeffrey 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 0 1 0 0 Chief Commercial Officer Common stock, par value $0.001 per share 2022-11-11 4 M 0 120000 2.86 A 120000 D Common stock, par value $0.001 per share 2022-11-11 4 S 0 120000 16.228 D 0 D Common stock, par value $0.001 per share 2022-11-11 4 M 0 19017 2.24 A 19017 D Common stock, par value $0.001 per share 2022-11-11 4 S 0 19017 15.461 D 0 D Options to purchase common stock 2.86 2022-11-11 4 M 0 120000 0 D 2019-08-06 Common Stock 120000 627000 D Options to purchase common stock 2.24 2022-11-11 4 M 0 19017 0 D 2019-12-19 Common Stock 19017 607983 D Shares were sold for personal reasons and does not relate to any disagreements with the Company. Mr. Del Carmen remains an officer of the Company. Shares were sold in various lots from $15.87 to $16.44 per share. The price listed represents a weighted average price for the shares sold. Shares were sold in various lots from $15.25 to $15.78 per share. The price listed represents a weighted average price for the shares sold. Options vested in four annual tranches beginning on August 6, 2019. Options vested in three annual tranches beginning on December 19, 2019. /s/ Jeffrey Del Carmen 2022-11-15